Korro Bio, Inc. (KRRO)
USD 44.46
(-10.65%)
USD 44.46
(-10.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -67.28 Million | -53.64 Million | -32.09 Million | -45.18 Million | 34.21 Million | -17.02 Million |
| Net Income | -81.17 Million | -58.03 Million | -21.95 Million | -26.51 Million | -18.74 Million | -19.16 Million |
| Depreciation & Amortization | 3.63 Million | 2.51 Million | 1.59 Million | 1.58 Million | 813 Thousand | 654 Thousand |
| Deferred income taxes | -15 Thousand | -145 Thousand | 28 Thousand | - | - | - |
| Stock-based compensation | 2.38 Million | 1.14 Million | 807 Thousand | - | - | - |
| Change in working capital | 4.28 Million | -633 Thousand | 904 Thousand | -30.24 Million | 48.64 Million | 819 Thousand |
| Other non-cash items | 3.61 Million | 1.51 Million | -13.46 Million | 8.85 Million | 5.77 Million | 1.97 Million |
| Investing Cash Flow | 11.16 Million | 11.06 Million | -39.5 Million | 10.4 Million | -18.26 Million | 3.33 Million |
| Investments in PPE | -7.83 Million | -5.21 Million | -4.44 Million | -6.67 Million | -1.06 Million | -436 Thousand |
| Acquisitions | - | - | -29.23 Million | - | - | 3.77 Million |
| Investment purchases | - | -37.21 Million | -35.06 Million | -26.34 Million | -282.61 Million | - |
| Sales/Maturities of investments | 19 Million | 53.48 Million | 29.23 Million | 43.41 Million | 265.42 Million | - |
| Other Investing Activities | 19 Thousand | 16.27 Thousand | 13 Thousand | - | - | - |
| Financing Cash Flow | 187.76 Million | 18 Thousand | 115.94 Million | 56.68 Million | 142.01 Million | 37.93 Million |
| Debt repayment | - | - | - | -15 Million | - | -5 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 117.25 Million | 62 Thousand | 1.35 Million | 41.68 Million | 142.01 Million | 32.93 Million |
| Other Financing Activities | 24.35 Million | -44 Thousand | -30 Thousand | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 3.1 Million | 1.75 Million | 56 Thousand | 4.28 Million | -644 Thousand | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.18 Million | -2.38 Million | 848 Thousand | -34.52 Million | 49.28 Million | 819 Thousand |
| Cash at beginning of period | 41.47 Million | 84.04 Million | 39.69 Million | 200.15 Million | 42.18 Million | 17.93 Million |
| Cash at end of period | 173.11 Million | 41.47 Million | 84.04 Million | 220.34 Million | 200.15 Million | 42.18 Million |
| Capital Expenditure | -7.83 Million | -5.21 Million | -4.44 Million | -6.67 Million | -1.06 Million | -436 Thousand |
| Effect of forex changes on cash | - | - | - | -1.71 Million | - | - |
| Net cash flow / Change in cash | 131.64 Million | -42.56 Million | 44.35 Million | 20.18 Million | 157.96 Million | 24.25 Million |
| Free Cash Flow | -75.11 Million | -58.85 Million | -36.54 Million | -51.85 Million | 33.15 Million | -17.46 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -21.82 Million | -19.55 Million | -81.17 Million | -39.21 Million | -11.61 Million | -10.79 Million |
| Depreciation & Amortization | 721 Thousand | 726 Thousand | 3.63 Million | 1.75 Million | 1.02 Million | 1.12 Million |
| Deferred income taxes | - | - | -15 Thousand | - | - | - |
| Stock-based compensation | 967 Thousand | 865 Thousand | 2.38 Million | 1.22 Million | 404 Thousand | 401 Thousand |
| Change in working capital | 4.6 Million | -5.12 Million | 4.28 Million | 2.5 Million | 2.85 Million | -1.54 Million |
| Other non-cash items | 1.27 Million | 6.1 Million | 3.61 Million | -7.33 Million | 5.93 Million | 6.16 Million |
| Investing Cash Flow | -102.39 Million | -5.61 Million | 11.16 Million | -20.36 Million | 6.81 Million | 19.21 Million |
| Investments in PPE | -5.96 Million | -5.61 Million | -7.83 Million | -7.73 Million | -246 Thousand | -4.42 Million |
| Acquisitions | - | - | - | -63 Thousand | 45 Thousand | 11 Thousand |
| Investment purchases | -96.43 Million | - | - | 1.97 Million | - | - |
| Sales/Maturities of investments | - | - | 19 Million | -14.54 Million | 6.77 Million | 19.2 Million |
| Other Investing Activities | -96.43 Million | - | 19 Thousand | - | 1 Million | 1000.00 |
| Financing Cash Flow | 67.55 Million | 139 Thousand | 187.76 Million | 201.89 Million | 2000.00 | -11.66 Million |
| Debt repayment | - | - | - | -14.16 Million | - | -11.66 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 67.55 Million | 139 Thousand | 117.25 Million | 163.37 Million | 2000.00 | - |
| Other Financing Activities | 67.55 Million | 139.00 | 24.35 Million | 24.35 Million | -2.19 Million | -76 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 2.07 Million | -2.58 Million | 3.1 Million | 5.87 Million | -956 Thousand | -1.12 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.52 Million | -2.54 Million | 1.18 Million | -3.36 Million | 3.81 Million | -418 Thousand |
| Cash at beginning of period | 142.35 Million | 169.71 Million | 41.47 Million | 41.72 Million | 39.71 Million | 40.85 Million |
| Cash at end of period | 92.92 Million | 142.35 Million | 173.11 Million | 169.71 Million | 41.72 Million | 39.71 Million |
| Capital Expenditure | -5.96 Million | -5.61 Million | -7.83 Million | -7.73 Million | -246 Thousand | -4.42 Million |
| Effect of forex changes on cash | - | - | - | -13.61 Million | -7000.00 | -261 Thousand |
| Net cash flow / Change in cash | -49.43 Million | -27.36 Million | 131.64 Million | 127.99 Million | 2.01 Million | -1.14 Million |
| Free Cash Flow | -20.55 Million | -27.5 Million | -75.11 Million | -47.66 Million | -5.04 Million | -12.84 Million |
BDC
LIFFF
300420
688276
KIERF
005930